Title
Current status of carbapenemases in Latin America
Date Issued
01 July 2013
Access level
metadata only access
Resource Type
review
Author(s)
Maya J.J.
Ruiz S.J.
Blanco V.M.
GOTUZZO HERENCIA, JOSE EDUARDO
Guzman-Blanco M.
Labarca J.
Salles M.
Quinn J.P.
Villegas M.V.
Publisher(s)
Taylor & Francis
Abstract
Enterobacteriaceae and non fermenting Gram-negative bacilli have become a threat to public health, in part due to their resistance to multiple antibiotic classes, which ultimately have led to an increase in morbidity and mortality. β-lactams are currently the mainstay for combating infections caused by these microorganisms, and β-lactamases are the major mechanism of resistance to this class of antibiotics. Within the β-lactamases, carbapenemases pose one of the gravest threats, as they compromise one of our most potent lines of defense, the carbapenems. Carbapenemases are being continuously identified worldwide; and in Latin America, numerous members of these enzymes have been reported. In this region, the high incidence of reports implies that carbapenemases have become a menace and that they are an issue that must be carefully studied and analyzed. © 2013 Informa UK Ltd.
Start page
657
End page
667
Volume
11
Issue
7
Language
English
OCDE Knowledge area
Epidemiología
Salud pública, Salud ambiental
Enfermedades infecciosas
Subjects
Scopus EID
2-s2.0-84880872131
Source
Expert Review of Anti-Infective Therapy
ISSN of the container
17448336
Sources of information:
Directorio de Producción Científica
Scopus